These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


411 related items for PubMed ID: 11505264

  • 1. A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
    Patton LL, Bonito AJ, Shugars DA.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):170-9. PubMed ID: 11505264
    [Abstract] [Full Text] [Related]

  • 2. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
    Pienaar ED, Young T, Holmes H.
    Cochrane Database Syst Rev; 2010 Nov 10; 2010(11):CD003940. PubMed ID: 21069679
    [Abstract] [Full Text] [Related]

  • 3. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
    Pienaar ED, Young T, Holmes H.
    Cochrane Database Syst Rev; 2006 Jul 19; (3):CD003940. PubMed ID: 16856025
    [Abstract] [Full Text] [Related]

  • 4. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S, Ellepola AN, Samaranayake LP.
    J Oral Pathol Med; 2001 Sep 19; 30(8):481-8. PubMed ID: 11545239
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH, Samaranayake LP, Tsang PC, Wong KH, Yeung KW.
    J Oral Pathol Med; 2001 Jul 19; 30(6):336-46. PubMed ID: 11459319
    [Abstract] [Full Text] [Related]

  • 6. Itraconazole and fluconazole in oropharyngeal candidiasis.
    van der Bijl P, Arendorf TM.
    Ann Dent; 1993 Jul 19; 52(2):12-6. PubMed ID: 8267372
    [Abstract] [Full Text] [Related]

  • 7. Outpatient therapy of HIV-associated oral and oesophageal candidosis.
    Ustianowski AP, Leake H, Evans S.
    Int J STD AIDS; 1997 Sep 19; 8(9):592-4. PubMed ID: 9292351
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.
    de Repentigny L, Ratelle J.
    Chemotherapy; 1996 Sep 19; 42(5):374-83. PubMed ID: 8874977
    [Abstract] [Full Text] [Related]

  • 9. [Therapy of candidiasis and cryptococcosis in AIDS].
    Just-Nübling G.
    Mycoses; 1994 Sep 19; 37 Suppl 2():56-63. PubMed ID: 7609745
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.
    Vazquez JA.
    HIV Clin Trials; 2000 Sep 19; 1(1):47-59. PubMed ID: 11590489
    [Abstract] [Full Text] [Related]

  • 12. Candidiasis at ICAAC.
    Barr D, Smart T.
    GMHC Treat Issues; 1995 Oct 19; 9(10):13. PubMed ID: 11362914
    [Abstract] [Full Text] [Related]

  • 13. [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
    Tebbe B, Boyvat A, Geilen CC, Wölfer LU, Seibold M, Orfanos CE.
    Hautarzt; 1996 Feb 19; 47(2):136-9. PubMed ID: 8868459
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
    Ellepola AN, Samaranayake LP.
    Dent Update; 2000 May 19; 27(4):165-70, 172-4. PubMed ID: 11218451
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of oropharyngeal candidiasis in HIV-positive patients.
    Greenspan D.
    J Am Acad Dermatol; 1994 Sep 19; 31(3 Pt 2):S51-5. PubMed ID: 7915732
    [Abstract] [Full Text] [Related]

  • 18. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.
    Ray A, Ray S, George AT, Swaminathan N.
    Cochrane Database Syst Rev; 2011 Aug 10; (8):CD008739. PubMed ID: 21833970
    [Abstract] [Full Text] [Related]

  • 19. [Oral candidiasis in HIV-seropositive patients and AIDS cases. Clinical, mycological and therapeutical aspects].
    Prieto Santa Anna LM, Illnait Zaragozi MT, Ramos Rodallegas EG, Lazcano Herrero B, Márquez Sánchez N, Cantelar de Francisco N, Manzur Katriba J, Martínez Machin G.
    Rev Cubana Med Trop; 2006 Aug 10; 58(3):173-80. PubMed ID: 23424783
    [Abstract] [Full Text] [Related]

  • 20. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E.
    Akush Ginekol (Sofiia); 2016 Aug 10; 55(4):20-29. PubMed ID: 29370489
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.